@article{7450ef5716874f1abf9b9846b1c3e25c,
title = "Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation",
abstract = "More than 40 000 hematopoietic cell transplants (HCTs) are performed worldwide each year. With improvements in transplant technology, larger numbers of transplant recipients survive free of the disease for which they were transplanted. However, there are late complications that can cause substantial morbidity. Many survivors are no longer under the care of transplant centers, and many community health care providers may be unfamiliar with health matters relevant to HCT. The Center for International Blood and Marrow Transplant Research (CIBMTR), European Group for Blood and Marrow Transplantation (EBMT), and American Society for Bone Marrow Transplantation (ASBMT) have developed these recommendations to offer care providers suggested screening and prevention practices for autologous and allogeneic HCT survivors.",
keywords = "HCT (hematopoietic cell transplantation), Late effects, Prevention, Screening",
author = "Rizzo, {J. Douglas} and Wingard, {John R.} and Andre Tichelli and Lee, {Stephanie J.} and {Van Lint}, {Maria Teresa} and Burns, {Linda J.} and Davies, {Stella M.} and Ferrara, {James L.M.} and G{\'e}rard Soci{\'e}",
note = "Funding Information: The Center for International Blood and Marrow Transplant Research is supported by Public Health Service grant no. U24-CA76518 from the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and the National Heart, Lung and Blood Institute; grant no. K23-CA-82350 from the National Institutes of Health, the National Cancer Institute Agency for Healthcare Research and Quality; Office of Naval Research; Health Resources Services Administration (Department of Health and Human Services); and grants from AABB, Aetna; AIG Medical Excess; American Red Cross; Amgen, Inc.; anonymous donation to the Medical College of Wisconsin; AnorMED, Inc.; Berlex Laboratories, Inc.; Biogen IDEC, Inc.; Blue Cross and Blue Shield Association; BRT Laboratories, Inc.; Celgene Corp.; Cell Therapeutics, Inc.; CelMed Biosciences; Cubist Pharmaceuticals; Dynal Biotech, LLC; Edwards Lifesciences RMI; Endo Pharmaceuticals, Inc.; Enzon Pharmaceuticals, Inc.; ESP Pharma; Fujisawa Healthcare, Inc.; Gambro BCT, Inc.; Genzyme Corporation; GlaxoSmithKline, Inc.; Histogenetics, Inc.; Human Genome Sciences; ILEX Oncology, Inc.; Kirin Brewery Company; Ligand Pharmaceuticals, Inc.; Merck & Company; Millennium Pharmaceuticals; Miller Pharmacal Group; Milliman USA, Inc.; Miltenyi Biotec; National Center for Biotechnology Information; National Leukemia Research Association; National Marrow Donor Program; NeoRx Corporation; Novartis Pharmaceuticals, Inc.; Novo Nordisk Pharmaceuticals; Ortho Biotech, Inc.; Osiris Therapeutics, Inc.; Pall Medical; Pfizer, Inc.; Pharmion Corp.; QOL Medical; Roche Laboratories; StemCyte, Inc.; Stemco Biomedical; StemSoft Software, Inc.; SuperGen, Inc.; Sysmex; The Marrow Foundation; THERAKOS, a Johnson & Johnson Co.; University of Colorado Cord Blood Bank; Valeant Pharmaceuticals; ViaCell, Inc.; ViraCor Laboratories; WB Saunders Mosby Churchill; and Wellpoint Health Network. European Group for Blood and Marrow Transplantation sponsors include Amgen Europe, Chugai-Aventis, F. Hoffman-LaRoche Ltd., Fresenius Biotech GmbH, Gambro BCT, GE Healthcare, Genzyme, Gilead Sciences UK, Miltenyi Biotec GmbH, Pierre Fabre, Pfizer, Schering AG, and Therakos. The authors wish to thank Karina Danner Koptik, RN, for her helpful critique of the recommendations, and Robilyn Lake and Sandy Sobotka for their assistance in manuscript preparation.",
year = "2006",
month = feb,
doi = "10.1016/j.bbmt.2005.09.012",
language = "English",
volume = "12",
pages = "138--151",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier B.V.",
number = "2",
}